Home 
Sitemap
Sitemap
Sitemap
Main Menu
- Home
- About AMS
- Mission and Vision
- AMS Executive and Council
- Education and Research Sub Committee
- Education and Research Fund
- AMS Young Investigator's Award Winners 2009
- Awards
- Membership Application
- Memorandum of Association
- The AMS Website
- Document on Conflict of Interest
- Accreditation
- Code of Ethics
- Privacy Statement
- Consumers
- Book Reviews
- Cochrane Reviews
- Ginkgo biloba for intermittent claudication
- Oral Contraceptives for functional ovarian cysts
- Steroidal Contraceptives: effect on bone fractures in women
- Testosterone for peri- and post-menopausal women
- Spironolactone versus placebo or in combination with steroids for hirsuitism and/or acne
- Selective serotonin reuptake inhibitors for premenstrual syndrome
- Progesterone or progesterone releasing IUD systems for heavy menstrual bleeding
- Progesterone for premenstrual syndrome
- Phytoestrogens for vasomotor symptoms
- Oral oestrogen and combined oestrogen/progestogen therapy versus placebo for hot flushes
- Antifibrinolytics for heavy menstrual bleeding
- Cyclical progestogens for heavy menstrual bleeding
- Exercise for vasomotor symptoms
- Hormone replacement therapy in postmenopausal women: endometrial hyperplasia and irregular bleeding
- Hysterectomy versus hysterectomy plus oophorectomy for premenopausal women
- Local oestrogen for vaginal atrophy in postmenopausal women
- Long term hormone therapy in perimenopausal and postmenopausal women
- Nonsteroidal anti-inflammatory drugs for heavy menstrual bleeding
- Oestrogen therapy for peri-menopausal and post-menopausal women: weight and body fat distribution
- Oral contraceptive pills for heavy menstrual bleeding
- Oral contraceptives containing drospirenone for premenstrual syndrome
- Information Sheets
- What is menopause?
- Glossary of Terms
- Vaginal Atrophy after Breast Cancer
- Vaginal Atrophy - a Change with Menopause
- AMS Guide to Equivalent HRT Doses
- Coping With Menopause - Depression
- Menopause – Oestrogen Only Therapy
- Contraception For Women Approaching Menopause
- Menopause and osteoporosis
- Low Libido and Testosterone Therapy
- The AMS Practitioners Guidelines for Oestradiol (E2) Implants
- WHI Study - Risks and Benefits graphs of HT/HRT
- The Role of SERMS after Menopause
- Sleep Disturbance and the Menopause
- NonHormonal Treatments for Menopausal Symptoms
- Bioidentical Hormones for Menopausal Symptoms
- Menopause and Body Changes
- Healthy Ageing and Lifestyle
- Early Menopause due to Chemotherapy
- Tibolone For Post-Menopausal Women
- Menopausal Treatments and the Risk of Blood Clots
- Treating the Menopause – the Concept of Risk and Benefit
- Early Menopause Due to Premature and Unexpected Ovarian Failure
- Menopause – Combined (Hormone Replacement Therapy)
- Diagnosing Menopause
- Position Statements
- RACGP Clinical Guideline for the Prevention and Treatment of Osteoporosis in Postmenopausal women and older men
- Estrogen & Progestogen use in Postmenopausal Women
- NAMS Position on Midlife Osteoporosis
- Ovarian Cancer Screening
- Aging, Menopause, Cardiovascular Disease & HRT
- IMS: HRT in the early menopause
- HRT & Breast Cancer
- Estrogen and progestogen use in postmenopausal women: July 2008
- HRT in the early menopause:
- IMS updated recommendations on postmenopausal hormone therapy
- Scientific Definitions for Menopause Related Terminology
- Resources
- Self Assessment Tools
- Video - Menopause: Evidence-based answers
- Find an AMS Doctor
- Health Professionals
- Book Reviews
- Cochrane Reviews
- Ginkgo biloba for intermittent claudication
- Oral Contraceptives for functional ovarian cysts
- Steroidal Contraceptives: effect on bone fractures in women
- Testosterone for peri- and post-menopausal women
- Spironolactone versus placebo or in combination with steroids for hirsuitism and/or acne
- Selective serotonin reuptake inhibitors for premenstrual syndrome
- Progesterone or progesterone releasing IUD systems for heavy menstrual bleeding
- Progesterone for premenstrual syndrome
- Phytoestrogens for vasomotor symptoms
- Oral oestrogen and combined oestrogen/progestogen therapy versus placebo for hot flushes
- Antifibrinolytics for heavy menstrual bleeding
- Cyclical progestogens for heavy menstrual bleeding
- Exercise for vasomotor symptoms
- Hormone replacement therapy in postmenopausal women: endometrial hyperplasia and irregular bleeding
- Hysterectomy versus hysterectomy plus oophorectomy for premenopausal women
- Local oestrogen for vaginal atrophy in postmenopausal women
- Long term hormone therapy in perimenopausal and postmenopausal women
- Nonsteroidal anti-inflammatory drugs for heavy menstrual bleeding
- Oestrogen therapy for peri-menopausal and post-menopausal women: weight and body fat distribution
- Oral contraceptive pills for heavy menstrual bleeding
- Oral contraceptives containing drospirenone for premenstrual syndrome
- Education
- Position Statements
- RACGP Clinical Guideline for the Prevention and Treatment of Osteoporosis in Postmenopausal women and older men
- Estrogen & Progestogen use in Postmenopausal Women
- NAMS Position on Midlife Osteoporosis
- Ovarian Cancer Screening
- Aging, Menopause, Cardiovascular Disease & HRT
- IMS: HRT in the early menopause
- HRT & Breast Cancer
- Estrogen and progestogen use in postmenopausal women: July 2008
- HRT in the early menopause:
- IMS updated recommendations on postmenopausal hormone therapy
- Scientific Definitions for Menopause Related Terminology
- Information Sheets
- What is menopause?
- Glossary of Terms
- Vaginal Atrophy after Breast Cancer
- Vaginal Atrophy - a Change with Menopause
- AMS Guide to Equivalent HRT Doses
- Coping With Menopause - Depression
- Menopause – Oestrogen Only Therapy
- Contraception For Women Approaching Menopause
- Menopause and osteoporosis
- Low Libido and Testosterone Therapy
- The AMS Practitioners Guidelines for Oestradiol (E2) Implants
- WHI Study - Risks and Benefits graphs of HT/HRT
- The Role of SERMS after Menopause
- Sleep Disturbance and the Menopause
- NonHormonal Treatments for Menopausal Symptoms
- Bioidentical Hormones for Menopausal Symptoms
- Menopause and Body Changes
- Healthy Ageing and Lifestyle
- Early Menopause due to Chemotherapy
- Tibolone For Post-Menopausal Women
- Menopausal Treatments and the Risk of Blood Clots
- Treating the Menopause – the Concept of Risk and Benefit
- Early Menopause Due to Premature and Unexpected Ovarian Failure
- Menopause – Combined (Hormone Replacement Therapy)
- Diagnosing Menopause
- GP & HP Resources
- Menopausal HRT
- Anti-Mullerian Hormone test
- IMS: Decline in breast cancer
- Menopause - cardiology workshop calls for action
- Assessment and Management of Cardiovascular Risks in Women
- Risk of Osteoporosis
- WHI and Beyond: Controversies in HRT
- The AMS Practitioners Guidelines for Oestradiol (E2) Implants
- Libido and the Natural Menopause Transition
- Low Libido: the Psychological Aspect
- The menopausal transition as a risk factor for sleep apnea in women
- Biomedical Literature Databases
- Recommended Journals
- Rosiglitazone for postmenopausal women with Type 2 diabetes
- Sleep disturbance during the menopause
- NHMRC booklet for health professionals
- Resources
- Self Assessment Tools
- Studies published
- SSRIs and Tamoxifen
- Multivitamins and Breast Cancer Risk
- Menopause and Incontinence
- Zolendronic acid efficacy
- Risk of Atherosclerosis
- Symptoms in Midlife
- Intravaginal therapy alternative to HRT
- DHEA benefit for sexual disfunction
- HRT and Lung Cancer - 21 September 2009
- The benefits of berries for the heart
- Herbs no help for cognition:study
- Ovarian Cancer risk from HRT
- HRT and the new incidence of diabetes mellitus
- Tapering HT reduces symptom recurrence
- Improving Sexual Function
- It's not the soy, it's the reporting bias
- Age at Menopause Increasing in Europe
- Rise in Use of Unregistered Hormones
- The benefits of oestrogen following menopause: Why HRT should be offered to postmenopause women
- Breast Cancer after use of E + P in Postmenopausal Women NEJM 2009
- Testosterone patch and sex drive in women
- Androgen therapy for loss of desire in women
- Obesity, Abnormal 'Reward Circuitry' in Brain Linked by Imaging Studies
- Study indicates aspirin may not prevent heart attack, stroke in high-risk patients
- Hormone therapy and risk of myocardial infarction: a national register study
- LIFT Trial
- WISDOM Trial
- Video - Menopause: Evidence-based answers
- Members
- Media
- 2009 October - World Menopause Day Information for women
- 2009 Jan 23 - Press Release Tibolone
- 2009 Jan 8 - HRT may be associated with reduced colorectal cancer risk.
- 2008 Nov 14 - Calcium, vitamin D do not lower breast-cancer risk
- 2008 Oct 18 - Women take heart – midlife, menopause and beyond
- 2008 Oct 6 - Hormone therapy and risk of myocardial infarction
- 2008 Aug 26 - LIFT Trial published
- 2008 Aug 22 - WISDOM Trial published
- 2008 Jun 11 - AMS response on HRT and Breast Cancer article
- 2008 Jan 15 - FDA Takes action against Compounded Menopause Hormone Therapy
- 2007 June 28 - Use of HRT for menopause related symptoms and disease prevention in apt women
- 2007 June 22 - AMS MEDIA RELEASE - Estrogen Therapy and Coronary-Artery Calcification
- 2007 April 24 - NEJM Special Report on Breast Cancer
- 2007 April 20 - Breast Cancer Incident and HRT Risk
- 2007 April 24 - Response to Lancet Paper on Ovarian Cancer in the Million Women Study
- Media Archives
- 2000 January 28 - AMS warns against reports of breast cancer/HRTcausing anxiety in HRTusers
- 2000 February 24 - Australasian Menopause Society reissues warning against misinterpreting new data
- 2000 March 24 - HRT And Established Heart Disease - implications from the HERS study
- 2000 April 7 - HRT and Cardiovascular Disease
- 2002 February 14 - The Risk of Breast Cancer With HRT Use
- 2002 July 10 - Initial response to the first report of the Women's Health Initiative
- 2002 July 16 - Report Expert Committee to the first report of the Women's Health Initiative
- 2002 July 25 - AMS response to the first report of the Womens Health Initiative
- 2006 October 17 - World Menopause Day Fact Sheet
- 2006 October 18 - WORLD MENOPAUSE DAY
- 2006 September 8 - The "Bioidentical/Bioequivalent" Hormone Scam
- 2006 August 26 - AMS Congratulates Professor Henry Burger
- 2006 May 23 - Unopposed Estrogen Therapy and the risk of Invasive Breast Cancer
- 2006 April 28 - New study results suggest oestrogen alone does not cause breast cancer
- 2005 September 7 - The risk of breast cancer and postmenopausal Hormone Therapy (HT)
- 2005 April 30 - Comments by Professor Alastair MacLennan - Million Women Study. Lancet 2005; 365 154
- 2005 April 30 - Comments by Professor Susan Davis - Million Women Study. Lancet 2005; 365:1543-51
- 2004 August 17 - Consensus meeting on hormone therapy - comment by Prof Susan Davis
- 2004 August 17 - HT Consensus Statement
- 2004 May 14 - Osteoporosis-New Resources for Health Professionals and Women
- 2004 March 3 - Women's Health initiative oestrogen-only vs placebo study terminated
- 2003 November 29 - Bioidentical hormones (troches) advice for doctors
- 2003 November 29 - Bioidentical hormones (troches) advice to consumers
- 2003 November 29 - Indications for Prescribing Oestrogens and Progestogens in Menopausal Women
- 2003 November 6 - Hormone Therapy Update
- 2003 June 25 - WHI Report - The Influence of Estrogen plus Progestin on Breast Cancer and Mammograph
- 2003 May 29 - WHI report on dementia, cognitive impairment and stroke - initial response
- 2002 November 20 - The risk of breast cancer with HRT use (AMS statement )
- 2002 November 1 - A new educational video is available to assist with counselling
- 2002 October 29 - AMS declines endorsement of New Zealand Guidelines Group
- 2002 October 18 - World Menopause Day
- 2002 October 29 - AMS declines endorsement of New Zealand Guidelines Group
- Studies Recruiting